Review
doi: 10.1016/0968-0004(92)90265-b.
How antibodies block HIV infection: paths to an AIDS vaccine
- PMID: 1350693
- DOI: 10.1016/0968-0004(92)90265-b
Item in Clipboard
Review
How antibodies block HIV infection: paths to an AIDS vaccine
Trends Biochem Sci.
1992 May.
Abstract
We are beginning to understand the mechanism that envelope proteins of the human and simian immunodeficiency viruses use to gain entry into host cells. A vaccine that can elicit antibodies that bind to the viral epitopes involved in this process would thereby prevent HIV infection. This article outlines our progress in the development of possible candidates for AIDS vaccines.
Similar articles
-
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network.J Infect Dis. 1993 Mar;167(3):533-7. doi: 10.1093/infdis/167.3.533. J Infect Dis. 1993. PMID: 8095059 Clinical Trial.
-
In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope.J Virol. 1996 Dec;70(12):9046-50. doi: 10.1128/JVI.70.12.9046-9050.1996. J Virol. 1996. PMID: 8971041 Free PMC article.
-
Humoral immune responses in human HIV-1 infection clearance of initial burst of virus replication and protection against disease progression.Int Rev Immunol. 1992;8(1):65-81. doi: 10.3109/08830189209056642. Int Rev Immunol. 1992. PMID: 1374113 Review.
-
Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response.J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jul;12(3):213-20. doi: 10.1097/00042560-199607000-00001. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8673525
-
Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design.Immunol Lett. 1997 Jun 1;57(1-3):105-12. doi: 10.1016/s0165-2478(97)00043-6. Immunol Lett. 1997. Corrected and republished in: Immunol Lett. 1997 Jul;58(2):125-32. doi: 10.1016/s0165-2478(97)00109-0. PMID: 9232434 Corrected and republished. Review.
Cited by
-
Artificial neural network method for predicting HIV protease cleavage sites in protein.J Protein Chem. 1998 Oct;17(7):607-15. doi: 10.1007/BF02780962. J Protein Chem. 1998. PMID: 9853675
-
Predicting cleavability of peptide sequences by HIV protease via correlation-angle approach.J Protein Chem. 1993 Jun;12(3):291-302. doi: 10.1007/BF01028191. J Protein Chem. 1993. PMID: 8397787
-
Studies on the specificity of HIV protease: an application of Markov chain theory.J Protein Chem. 1993 Dec;12(6):709-24. doi: 10.1007/BF01024929. J Protein Chem. 1993. PMID: 8136021
-
Peptide bioinformatics: peptide classification using peptide machines.Methods Mol Biol. 2008;458:159-83. doi: 10.1007/978-1-60327-101-1_9. Methods Mol Biol. 2008. PMID: 19065810 Free PMC article. Review.
-
Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives.Adv Biol. 2014;2014:157895. doi: 10.1155/2014/157895. Epub 2014 Sep 9. Adv Biol. 2014. PMID: 27099867 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
